3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
10
Colorectal Neoplasms
9
Rectal Neoplasms
8
Pancreatic Neoplasms
8
Wilms Tumor
7
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Glioma
7
Sarcoma
6
Rhabdomyosarcoma
6
Rhabdoid Tumor
6
Osteosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Lung Neoplasms
5
Central Nervous System Neoplasms
5
Stomach Neoplasms
4
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Melanoma
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Lymphoma
2
Liver Neoplasms
2
Interventions
Oxaliplatin
3
Fluorouracil
3
Radiotherapy
2
Immune Checkpoint Inhibitors
2
Endoscopy
2
Drug Therapy
2
Chemoradiotherapy
2
toripalimab
1
tislelizumab
1
pembrolizumab
1
X-Rays
1
Tretinoin
1
TP protocol
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proctectomy
1
Positron Emission Tomography Computed Tomography
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Immunotherapy
1
Immunohistochemistry
1
Esophagectomy
1
Epirubicin
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Docetaxel
1
Diffusion Magnetic Resonance Imaging
1
Cisplatin
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
X-Rays
×
Gastrointestinal
×
Clear all
NCT02233374
2022-10-28
PRISM
Royal North Shore Hospital
Phase NA
Completed
27 enrolled